Skip to content

Questionnaire Follow=up Study Sonia 2

Questionnaire Follow=up Study Sonia 2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04510142
Acronym
QSonia
Enrollment
24
Registered
2020-08-12
Start date
2019-09-19
Completion date
2023-08-31
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alkaptonuria, Alkaptonuria Severity Score Index, Homogentisate Dioxygenase, Homogentisic Acid

Keywords

Royal Liverpool University Hospital

Brief summary

Survey of health of patients completing SONIA 2 study: A cross-sectional analysis by questionnaire

Detailed description

The Liverpool site will post the once only, short questionnaire (in the correct language using translated documents as appropriate) to the address of those patients who completed SONIA 2. Hospital approved translation services will be used. A return-addressed stamped envelope for ease of return will also be provided. Those who received nitisinone will be sent the nitisinone-administration questionnaire and those who did not receive nitisinone will be sent a no-nitisinone questionnaire

Interventions

None listed

Sponsors

Liverpool University Hospitals NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- Documented diagnosis of AKU. Age ≥16 years.

Exclusion criteria

\- Not completed SONIA 2 study for the full 4-year duration.

Design outcomes

Primary

MeasureTime frameDescription
to collect information on their health status since completing participation in SONIA 212 monthsAll of the SONIA 2 completed questionnaire data collection is completed by 2 Sept 2020

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026